CPRX Archived Articles
Catalyst Pharmaceuticals (CPRX): Navigating the Rare Disease Landscape with Unwavering Commitment
Published on November 05, 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Diversifying Its Rare Disease Portfolio with Promising Launches
Published on September 24, 2024